The stock of GRI Bio Inc (GRI) has gone down by -11.32% for the week, with a -7.01% drop in the past month and a 86.02% rise in the past quarter. The volatility ratio for the week is 10.45%, and the volatility levels for the past 30 days are 10.54% for GRI. The simple moving average for the past 20 days is -9.34% for GRI’s stock, with a -68.02% simple moving average for the past 200 days.
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
The stock has a 36-month beta value of -2.14. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GRI is 8.93M, and at present, short sellers hold a 3.49% of that float. On January 10, 2025, the average trading volume of GRI was 4.29M shares.
GRI) stock’s latest price update
GRI Bio Inc (NASDAQ: GRI)’s stock price has dropped by -11.13 in relation to previous closing price of 0.83. Nevertheless, the company has seen a loss of -11.32% in its stock price over the last five trading days. globenewswire.com reported 2024-12-23 that – Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators
Analysts’ Opinion of GRI
Many brokerage firms have already submitted their reports for GRI stocks, with H.C. Wainwright repeating the rating for GRI by listing it as a “Buy.” The predicted price for GRI in the upcoming period, according to H.C. Wainwright is $10 based on the research report published on December 09, 2024 of the previous year 2024.
GRI Trading at -8.04% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.87% of loss for the given period.
Volatility was left at 10.54%, however, over the last 30 days, the volatility rate increased by 10.45%, as shares sank -15.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.44% upper at present.
During the last 5 trading sessions, GRI fell by -11.32%, which changed the moving average for the period of 200-days by -92.78% in comparison to the 20-day moving average, which settled at $0.8102. In addition, GRI Bio Inc saw -11.32% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.54 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -2.22. Equity return is now at value -280.75, with -167.58 for asset returns.
Currently, EBITDA for the company is -10.9 million with net debt to EBITDA at 0.56. When we switch over and look at the enterprise to sales, we see a ratio of 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.10.
Conclusion
To sum up, GRI Bio Inc (GRI) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
